Free Trial

Spruce Biosciences (SPRB) SEC Filings & 10K Form

Spruce Biosciences logo
$0.55
+0.02 (+3.79%)
(As of 11/1/2024 ET)

Recent Spruce Biosciences SEC Filings

DateFilerForm TypeView
10/28/2024
4:15 PM
Spruce Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/23/2024
1:26 PM
Rosalind Advisors, Inc. (Filed by)
Spruce Biosciences (Subject)
Form SC 13G/A
08/12/2024
3:18 PM
Spruce Biosciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/12/2024
3:09 PM
Spruce Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/03/2024
6:05 AM
Spruce Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/24/2024
3:05 PM
Spruce Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/25/2024
5:52 PM
Rosalind Advisors, Inc. (Filed by)
Spruce Biosciences (Subject)
Form SC 13G/A
04/05/2024
3:26 PM
Spruce Biosciences (Filer)
Form ARS
04/05/2024
3:12 PM
Spruce Biosciences (Filer)
Form DEF 14A
04/05/2024
3:18 PM
Spruce Biosciences (Filer)
Form DEFA14A
03/28/2024
8:15 PM
Novo Holdings A/S (Filed by)
Spruce Biosciences (Subject)
Form SC 13D/A
03/28/2024
11:42 AM
Radoff Bradley Louis (Filed by)
Spruce Biosciences (Subject)
Form SC 13G
03/25/2024
8:45 PM
Novo Holdings A/S (Reporting)
Spruce Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/25/2024
8:48 PM
Novo Holdings A/S (Filed by)
Spruce Biosciences (Subject)
Form SC 13D/A
03/20/2024
8:31 PM
Novo Holdings A/S (Filed by)
Spruce Biosciences (Subject)
Form SC 13D/A
03/20/2024
7:56 PM
Novo Holdings A/S (Reporting)
Spruce Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2024
8:14 PM
Novo Holdings A/S (Reporting)
Spruce Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2024
8:16 PM
Novo Holdings A/S (Filed by)
Spruce Biosciences (Subject)
Form SC 13D/A
03/18/2024
8:20 PM
Novo Holdings A/S (Reporting)
Spruce Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/18/2024
3:27 PM
Spruce Biosciences (Issuer)
Szwarcberg Javier B. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2024
3:29 PM
Gharib Samir M. (Reporting)
Spruce Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2024
3:31 PM
Charlton Ralph William III (Reporting)
Spruce Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/14/2024
8:00 PM
Novo Holdings A/S (Reporting)
Spruce Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/13/2024
3:12 PM
Spruce Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2024
3:57 PM
CITADEL ADVISORS LLC (Filed by)
Spruce Biosciences (Subject)
Form SC 13G/A
02/14/2024
1:11 PM
Rock Springs Capital Management LP (Filed by)
Spruce Biosciences (Subject)
Form SC 13G/A
01/30/2024
10:06 AM
Rosalind Advisors, Inc. (Filed by)
Spruce Biosciences (Subject)
Form SC 13G
01/08/2024
7:00 AM
Spruce Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/18/2023
7:15 PM
Spruce Biosciences (Issuer)
Szwarcberg Javier B. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2023
7:16 PM
Gharib Samir M. (Reporting)
Spruce Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2023
7:17 PM
Charlton Ralph William III (Reporting)
Spruce Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/28/2023
6:00 PM
Spruce Biosciences (Issuer)
Szwarcberg Javier B. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2023
6:01 PM
Gharib Samir M. (Reporting)
Spruce Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:SPRB) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners